Dimensional Fund Advisors LP Kala Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.61 - $1.84 $36,428 - $109,882	-59,719 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$1.16 - $2.74 $104,161 - $246,035	-89,794 Reduced 60.06%	59,719 $72,000
Q3 2021 Nov 12, 2021	SELL	$2.62 - $5.43 $654,871 - $1.36 Million	-249,951 Reduced 62.57%	149,513 $392,000
Q2 2021 Aug 12, 2021	SELL	$5.06 - $8.15 $340,274 - $548,071	-67,248 Reduced 14.41%	399,464 $2.12 Million
Q1 2021 May 14, 2021	SELL	$6.24 - $9.58 $58,075 - $89,161	-9,307 Reduced 1.96%	466,712 $3.15 Million
Q4 2020 Feb 25, 2021	BUY	$6.28 - $8.79 $2.99 Million - $4.18 Million	476,019 New	476,019 $3.23 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.